Results 31 to 40 of about 87,373 (338)

"Myeloma Protein" in a Patient with Monocytic Leukemia [PDF]

open access: yesBlood, 1969
Abstract A 74 year old man with monocytic leukemia was found to have serum and urinary protein findings typical of myelomatosis. Lysozyme excretion in the urine was in the range characteristic of monocytic leukemia. There were no x-ray findings indicative of myeloma.
Lawrence Berman   +2 more
openaire   +3 more sources

Elotuzumab as a novel anti-myeloma immunotherapy

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Treatment of multiple myeloma has undergone significant change in the last decade with the introduction of new immunomodulatory agents, proteasome inhibitors, and immunotherapeutic approaches.
Sabarinath Venniyil Radhakrishnan   +5 more
doaj   +1 more source

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies

open access: yesHaematologica, 2014
A multistep model has been proposed of disease progression starting in monoclonal gammopathy of undetermined significance continuing through multiple myeloma, sometimes with an intermediate entity called smoldering myeloma, and ending in extramedullary ...
Lucía López-Corral   +15 more
doaj   +1 more source

Multiple Myeloma Cancer Cell Instance Segmentation [PDF]

open access: yesarXiv, 2021
Images remain the largest data source in the field of healthcare. But at the same time, they are the most difficult to analyze. More than often, these images are analyzed by human experts such as pathologists and physicians. But due to considerable variation in pathology and the potential fatigue of human experts, an automated solution is much needed ...
arxiv  

Determining Optimal Combination Regimens for Patients with Multiple Myeloma [PDF]

open access: yesarXiv, 2022
While many novel therapies have been approved in recent years for treating patients with multiple myeloma, there is still no established curative regimen, especially for patients with high risk disease. In this work, we use a mathematical modeling approach to determine combination therapy regimens that maximize healthy lifespan for patients with ...
arxiv  

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Intrahepatic cholangiocarcinoma (ICC) is a deadly but poorly understood disease, and its treatment options are very limited. The aim of this study was to identify the molecular drivers of ICC and search for therapeutic targets.
Yuto Shiode   +16 more
wiley   +1 more source

Type I-conventional dendritic cells support the progression of multiple myeloma in the bone marrow

open access: yesFrontiers in Immunology
PurposeType I conventional dendritic cells (cDC1s) play a key role in priming anti-tumor cytotoxic T cells and inducing immune tolerance for self-antigens and tumor antigens. However, it remains unclear whether cDC1 has a protective or pathogenic role in
Sayaka Suzuki   +10 more
doaj   +1 more source

Heat shock proteins in multiple myeloma [PDF]

open access: yesOncotarget, 2014
Heat shock proteins are molecular chaperones with a central role in protein folding and cellular protein homeostasis. They also play major roles in the development of cancer and in recent years have emerged as promising therapeutic targets. In this review, we discuss the known molecular mechanisms of various heat shock protein families and their ...
Jacqueline H. L. Fok   +2 more
openaire   +3 more sources

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma

open access: yesBMC Cancer, 2017
Background Because glycosylation is one of the most common post-translational modifications of proteins and because changes in glycosylation have been shown to have a significant correlation with the development of many cancer types, we investigated the ...
Jie Chen   +9 more
doaj   +1 more source

Prognostic value of plasmablastic morphology and p21, p53 and Cyclin D1 expression in myeloma cells: retrospective study of 122 patients with newly diagnosed multiple myeloma

open access: yesBiotechnology & Biotechnological Equipment, 2021
Multiple myeloma (MM) is the most common bone marrow malignancy which is defined with bone marrow infiltration of more than 10% of terminally differentiated plasma cells sive myeloma cells.
Jurijs Nazarovs   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy